Nov 28, 2014 at 08:39 | Source: CNBC-TV18
ITC | Dr Reddy's Labs | Punjab National Bank | JSW Steel | Cox & Kings | Wintac | Syndicate Bank | Suven Life Sciences | Just Dial | AstraZeneca Pharma | IL&FS Engineering | BF Utilities | MTNL | Financial Technologies | Radha Madhav Corporation are stocks, which are in the news today.
Nov 26, 2014 at 14:34 | Source: PTI
Ranbaxy Laboratories had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.
Nov 25, 2014 at 11:05 | Source: CNBC-TV18
Sanjay Dutt, Director at Quantum Securities is of the view that one may prefer Sun Pharmaceutical Industries.
Nov 25, 2014 at 08:44 | Source: CNBC-TV18
CNBC-TV18's Research Team recommends Top 10 stocks to watch in today's trade - Crompton Greaves, Jindal Saw, Amtek Auto, Ahmednagar Forgings, Amara Raja, Bharti Airtel, Ranbaxy, Ceat, TV Today and HDFC Bank.
Nov 24, 2014 at 14:15 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Hon'ble High Court of Gujarat at Ahmedabad, at its hearing held on November 14, 2014, has sanctioned the Scheme of Arrangement in the nature of Merger of Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.
Nov 22, 2014 at 14:25 | Source: PTI
The comments with respect to the Holcim-Lafarge deal need to be submitted to the CCI (Competition Commission of India) within 15 days, along with supporting documents on how the merger can adversely impact the concerned person or entity, the regulator said, adding that it would not consider 'unsubstantiated objections' to the deal.
Nov 21, 2014 at 10:00 | Source: CNBC-TV18
Ajay Srivastava is bullish on cement, tyre, IT and pharma space. Among stocks, Srivastava likes JK Lakshmi, Shree cement, Sun Pharma, Lupin, Tech Mahindra, Infosys and Oracle.
Nov 20, 2014 at 13:31 | Source: CNBC-TV18
Mithil Pradhan of Violet Arc Global Managers recommends going long in Cipla with a target of Rs 650-670.
Nov 20, 2014 at 13:04 | Source: CNBC-TV18
Once the closure of the merger (Sun-Ranbaxy) is done and market begins to take due notice of the benefits that can come through on the acquisition the stock will not look that expensive thereon, says Nitin Agrawal.
Nov 20, 2014 at 12:48 | Source: CNBC-TV18
Watch the interview of Mithil Pradhan of Violet Arc Global Managers with Sonia Shenoy and Anuj Singhal on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.